Curaleaf Holdings (CURLF) Shares Outstanding (Weighted Average) (2019 - 2026)
Curaleaf Holdings (CURLF) recorded quarterly Shares Outstanding (Weighted Average) of $90.0 in Q1 2026, down 100.0% quarter-over-quarter from $762.1 million in Q4 2025, and down 100.0% on a YoY basis from $744.9 million in Q1 2025.
Curaleaf Holdings (CURLF) Shares Outstanding (Weighted Average) (2019 - 2026) Analysis & Trends
Curaleaf Holdings' Shares Outstanding (Weighted Average) history runs 8 years deep, the most recent figure standing at $90.0 for Q1 2026.
- In Q1 2026, Shares Outstanding (Weighted Average) fell 100.0% year-over-year to $90.0; the TTM figure through Mar 2026 stood at $90.0 (down 100.0% YoY), while the FY2025 annual figure was $762.1 million, up 2.87% from the prior year.
- Shares Outstanding (Weighted Average) was $90.0 for Q1 2026 at Curaleaf Holdings, down from $762.1 million in the prior quarter.
- In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $762.1 million in Q4 2025 to a low of $90.0 in Q1 2026.
- Historically, Shares Outstanding (Weighted Average) has averaged $680.1 million across 5 years, with a median of $730.7 million in 2023.
- The sharpest annual moves came in 2022 and 2026: Shares Outstanding (Weighted Average) climbed 3.94% in 2022, then sank 100.0% in 2026.
- A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $709.6 million in 2022, then rose by 2.04% to $724.1 million in 2023, then increased by 2.31% to $740.8 million in 2024, then gained by 2.87% to $762.1 million in 2025, then plunged by 100.0% to $90.0 in 2026.
- The last three Shares Outstanding (Weighted Average) figures came in at $90.0 (Q1 2026), $762.1 million (Q4 2025), and $757.3 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 1.16 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 422.10 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 43.50 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 5.02 Bn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 100.50 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 497.70 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 166.20 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 64.74 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 228.36 Mn |
| 10 | Curaleaf Holdings | - | - | 157.29 Mn | 90.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 90.00 |
| Dec 31, 2025 | 762.09 Mn |
| Jun 30, 2025 | 757.27 Mn |
| Mar 31, 2025 | 744.90 Mn |
| Dec 31, 2024 | 740.83 Mn |
| Sep 30, 2024 | 742.54 Mn |
| Jun 30, 2024 | 740.79 Mn |
| Mar 31, 2024 | 736.15 Mn |
| Dec 31, 2023 | 724.12 Mn |
| Sep 30, 2023 | 725.32 Mn |
| Jun 30, 2023 | 719.27 Mn |
| Sep 30, 2022 | 709.64 Mn |
| Jun 30, 2022 | 709.97 Mn |
| Mar 31, 2022 | 708.90 Mn |
| Dec 31, 2021 | 2.23 Bn |
| Sep 30, 2021 | 703.55 Mn |
| Jun 30, 2021 | 701.67 Mn |
| Mar 31, 2021 | 682.04 Mn |
| Dec 31, 2020 | 1.75 Bn |
| Sep 30, 2020 | 1.73 Bn |